B3GNT9
Basic information
Region (hg38): 16:67148104-67150998
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the B3GNT9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 0 | 0 |
Variants in B3GNT9
This is a list of pathogenic ClinVar variants found in the B3GNT9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-67149390-C-G | not specified | Uncertain significance (May 18, 2022) | ||
16-67149444-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
16-67149449-G-A | not specified | Uncertain significance (Feb 17, 2022) | ||
16-67149483-C-A | not specified | Uncertain significance (Nov 01, 2022) | ||
16-67149486-G-T | not specified | Uncertain significance (Nov 11, 2024) | ||
16-67149509-A-C | not specified | Uncertain significance (Apr 05, 2023) | ||
16-67149514-C-G | not specified | Uncertain significance (Nov 19, 2024) | ||
16-67149566-G-A | not specified | Uncertain significance (May 20, 2024) | ||
16-67149593-G-A | not specified | Uncertain significance (Oct 01, 2024) | ||
16-67149621-C-T | not specified | Uncertain significance (Sep 27, 2024) | ||
16-67149630-A-G | not specified | Uncertain significance (Mar 25, 2022) | ||
16-67149692-C-T | not specified | Uncertain significance (Nov 28, 2024) | ||
16-67149702-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
16-67149729-G-T | not specified | Uncertain significance (Jul 26, 2022) | ||
16-67149738-G-C | not specified | Uncertain significance (Jul 30, 2024) | ||
16-67149776-C-T | not specified | Uncertain significance (Nov 15, 2024) | ||
16-67149837-C-G | not specified | Uncertain significance (Jun 29, 2023) | ||
16-67149848-G-C | not specified | Uncertain significance (Oct 05, 2023) | ||
16-67149899-G-T | not specified | Uncertain significance (Sep 01, 2021) | ||
16-67149947-G-A | not specified | Uncertain significance (Dec 09, 2024) | ||
16-67150006-C-G | not specified | Uncertain significance (Dec 03, 2024) | ||
16-67150031-C-G | not specified | Uncertain significance (Oct 09, 2024) | ||
16-67150047-C-G | not specified | Uncertain significance (Dec 05, 2024) | ||
16-67150059-C-T | not specified | Uncertain significance (Apr 12, 2024) | ||
16-67150085-G-A | not specified | Uncertain significance (Mar 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
B3GNT9 | protein_coding | protein_coding | ENST00000449549 | 1 | 3110 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000174 | 0.268 | 124543 | 0 | 17 | 124560 | 0.0000682 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.09 | 176 | 222 | 0.794 | 0.0000148 | 2443 |
Missense in Polyphen | 80 | 99.916 | 0.80067 | 1141 | ||
Synonymous | -0.572 | 122 | 114 | 1.07 | 0.00000880 | 907 |
Loss of Function | -0.133 | 7 | 6.63 | 1.06 | 3.18e-7 | 82 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000111 | 0.000106 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000134 | 0.000131 |
Other | 0.000166 | 0.000165 |
dbNSFP
Source:
- Pathway
- Post-translational protein modification;Metabolism of proteins;O-linked glycosylation of mucins;O-linked glycosylation
(Consensus)
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.354
- ghis
- 0.463
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- B3gnt9
- Phenotype
Gene ontology
- Biological process
- protein glycosylation;poly-N-acetyllactosamine biosynthetic process
- Cellular component
- Golgi membrane;fibrillar center;endoplasmic reticulum;Golgi apparatus;integral component of membrane
- Molecular function
- acetylgalactosaminyltransferase activity;galactosyltransferase activity;N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity